KRONOS WORLDWIDE INC overview

EQS Newswire / 11/10/2024 / 02:45 CET/CEST Kronos Research has strengthened its leadership team with a focus on enhancing the firm's commitment to innovation through collaboration and technical excellence SINGAPORE - Media OutReach Newswire - 11 October 2024 - Kronos Research, a leading quant-trading firm and market maker, has strengthened its leadership team with the appointment of Vincent Wang as Chief Technology Officer (CTO), a pivotal role focused on enhancing the firm's commitment to...

King Street and Kronos Homes complete the sale of Palmares Ocean Living and Golf PR Newswire LONDON, Nov. 28, 2023 LONDON , Nov. 28, 2023 /PRNewswire/ -- King Street Capital Management ("King Street"), a leading global alternative investment firm, and Kronos Homes, a Spanish real estate investor and developer, today announced they have completed the sale of the Palmares Ocean Living & Golf ("Palmares" or "the resort") to funds managed by Arrow Global. The sale follows six years of extensive...

Kronos Research joins Token 2049 to strengthen its market-making foothold in Asia PR Newswire SINGAPORE, Sept. 12, 2023 SINGAPORE , Sept. 12, 2023 /PRNewswire/ -- TOKEN 2049 - Kronos Research is bullish on the growth of virtual assets-related projects in Asia as its new leadership meets with partners at Token 2049, Asia's largest Web3 gathering for decision-makers across the spectrum of traditional finance, big tech, and global regulators, crypto-native entrepreneurs, and builders. In a...

Kronos Research joins Token 2049 to strengthen its market-making foothold in Asia PR Newswire SINGAPORE, Sept. 12, 2023 SINGAPORE , Sept. 12, 2023 /PRNewswire/ -- TOKEN 2049 - Kronos Research is bullish on the growth of virtual assets-related projects in Asia as its new leadership meets with partners at Token 2049, Asia's largest Web3 gathering for decision-makers across the spectrum of traditional finance, big tech, and global regulators, crypto-native entrepreneurs, and builders. In a...

Davidson Kempner, Highgate and Kronos complete acquisition of ECS PR Newswire NEW YORK, LONDON and LISBON, Jan. 4, 2023 NEW YORK , LONDON and LISBON , Jan. 4, 2023 /PRNewswire/ -- A consortium led by investment funds advised by Davidson Kempner Capital Management LP, and comprising operating partners Highgate and Kronos ("the Consortium") has completed the acquisition ("the Transaction") of leading Portuguese investment manager ECS Capital ("ECS"). Financial terms of the Transaction have not...

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML PR Newswire SAN MATEO, Calif. and SAN DIEGO, Aug. 17, 2022 Companion diagnostic would be used following potential regulatory approval of entospletinib to screen for NPM1 mutation present in approximately one-third of all patients with AML Entospletinib is currently being studied in the Phase 3 AGILITY registrational study, with data...

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML PR Newswire SAN MATEO, Calif. and SAN DIEGO, Aug. 16, 2022 Companion diagnostic would be used following potential regulatory approval of entospletinib to screen for NPM1 mutation present in approximately one-third of all patients with AML Entospletinib is currently being studied in the Phase 3 AGILITY registrational study, with data...

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML PR Newswire SAN MATEO, Calif. and SAN DIEGO, Aug. 16, 2022 Companion diagnostic would be used following potential regulatory approval of entospletinib to screen for NPM1 mutation present in approximately one-third of all patients with AML Entospletinib is currently being studied in the Phase 3 AGILITY registrational study, with data...